Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 18 entries
Sorted by: Best Match Show Resources per page
A master dynamic flow diagram for the shear thickening transition in micellar solutions.

Soft matter

Bautista F, Tepale N, Fernández VV, Landázuri G, Hernández E, Macías ER, Soltero JF, Escalante JI, Manero O, Puig JE.
PMID: 26448618
Soft Matter. 2016 Jan 07;12(1):165-70. doi: 10.1039/c5sm01625h.

The shear thickening behavior of dilute micellar solutions of hexadecyltrimethylammonium-type surfactants with different counterions (tosylate, 3- and 4-fluorobenzoate, vinylbenzoate and salicylate) and of n-alkyltetradecylammonium bromide (CnTAB), with n = 14, 16 and 18, is examined here. These solutions undergo...

Cite
Bautista F, Tepale N, Fernández VV, et al. A master dynamic flow diagram for the shear thickening transition in micellar solutions. Soft Matter. 2016;12(1):165-70doi: 10.1039/c5sm01625h.
Bautista, F., Tepale, N., Fernández, V. V., Landázuri, G., Hernández, E., Macías, E. R., Soltero, J. F., Escalante, J. I., Manero, O., & Puig, J. E. (2016). A master dynamic flow diagram for the shear thickening transition in micellar solutions. Soft matter, 12(1), 165-70. https://doi.org/10.1039/c5sm01625h
Bautista, F, et al. "A master dynamic flow diagram for the shear thickening transition in micellar solutions." Soft matter vol. 12,1 (2016): 165-70. doi: https://doi.org/10.1039/c5sm01625h
Bautista F, Tepale N, Fernández VV, Landázuri G, Hernández E, Macías ER, Soltero JF, Escalante JI, Manero O, Puig JE. A master dynamic flow diagram for the shear thickening transition in micellar solutions. Soft Matter. 2016 Jan 07;12(1):165-70. doi: 10.1039/c5sm01625h. PMID: 26448618.
Copy Download .nbib Format: NLM
Metal and Metalloid Contaminants in Atmospheric Aerosols from Mining Operations.

Water, air, and soil pollution

Csavina J, Landázuri A, Wonaschütz A, Rine K, Rheinheimer P, Barbaris B, Conant W, Sáez AE, Betterton EA.
PMID: 23441050
Water Air Soil Pollut. 2011 Oct;221(1):145-157. doi: 10.1007/s11270-011-0777-x.

Mining operations are potential sources of airborne metal and metalloid contaminants through both direct smelter emissions and wind erosion of mine tailings. The warmer, drier conditions predicted for the Southwestern US by climate models may make contaminated atmospheric dust...

Cite
Csavina J, Landázuri A, Wonaschütz A, et al. Metal and Metalloid Contaminants in Atmospheric Aerosols from Mining Operations. Water Air Soil Pollut. 2011;221(1):145-157doi: 10.1007/s11270-011-0777-x.
Csavina, J., Landázuri, A., Wonaschütz, A., Rine, K., Rheinheimer, P., Barbaris, B., Conant, W., Sáez, A. E., & Betterton, E. A. (2011). Metal and Metalloid Contaminants in Atmospheric Aerosols from Mining Operations. Water, air, and soil pollution, 221(1), 145-157. https://doi.org/10.1007/s11270-011-0777-x
Csavina, Janae, et al. "Metal and Metalloid Contaminants in Atmospheric Aerosols from Mining Operations." Water, air, and soil pollution vol. 221,1 (2011): 145-157. doi: https://doi.org/10.1007/s11270-011-0777-x
Csavina J, Landázuri A, Wonaschütz A, Rine K, Rheinheimer P, Barbaris B, Conant W, Sáez AE, Betterton EA. Metal and Metalloid Contaminants in Atmospheric Aerosols from Mining Operations. Water Air Soil Pollut. 2011 Oct;221(1):145-157. doi: 10.1007/s11270-011-0777-x. PMID: 23441050; PMCID: PMC3576728.
Copy Download .nbib Format: NLM
Network radiofrequency ablation for drug resistant epilepsy.

Epilepsy & behavior reports

Shamim D, Cheng J, Pearson C, Landazuri P.
PMID: 34381989
Epilepsy Behav Rep. 2021 Jul 14;16:100471. doi: 10.1016/j.ebr.2021.100471. eCollection 2021.

Radiofrequency ablation (RFA) is a minimally invasive procedure for drug-resistant focal epilepsy. Although well tolerated, seizure outcomes are less favorable than standard resection. RFA is commonly performed following stereoencephalography (sEEG) identification of the seizure onset zone (SOZ). We hypothesized...

Cite
Shamim D, Cheng J, Pearson C, et al. Network radiofrequency ablation for drug resistant epilepsy. Epilepsy Behav Rep. 2021;16:100471doi: 10.1016/j.ebr.2021.100471.
Shamim, D., Cheng, J., Pearson, C., & Landazuri, P. (2021). Network radiofrequency ablation for drug resistant epilepsy. Epilepsy & behavior reports, 16100471. https://doi.org/10.1016/j.ebr.2021.100471
Shamim, Daniah, et al. "Network radiofrequency ablation for drug resistant epilepsy." Epilepsy & behavior reports vol. 16 (2021): 100471. doi: https://doi.org/10.1016/j.ebr.2021.100471
Shamim D, Cheng J, Pearson C, Landazuri P. Network radiofrequency ablation for drug resistant epilepsy. Epilepsy Behav Rep. 2021 Jul 14;16:100471. doi: 10.1016/j.ebr.2021.100471. eCollection 2021. PMID: 34381989; PMCID: PMC8335629.
Copy Download .nbib Format: NLM
Adsorption and Interaction of Bovine Serum Albumin and Pluronic P103 Triblock Copolymer on a Gold Electrode: Double-Layer Capacitance Measurements.

ACS omega

Velasco-Rodriguez B, Soltero-Martínez JF, Rosales-Rivera LC, Macías-Balleza ER, Landázuri G, Larios-Durán ER.
PMID: 32715219
ACS Omega. 2020 Jul 08;5(28):17347-17355. doi: 10.1021/acsomega.0c01704. eCollection 2020 Jul 21.

The interactions of proteins and other molecules and their adsorption onto substrates is a fascinating topic that has been applied to surface technologies, biosensors, corrosion studies, biotechnologies, and other fields. The success of these applications requires a previous characterization...

Cite
Velasco-Rodriguez B, Soltero-Martínez JF, Rosales-Rivera LC, et al. Adsorption and Interaction of Bovine Serum Albumin and Pluronic P103 Triblock Copolymer on a Gold Electrode: Double-Layer Capacitance Measurements. ACS Omega. 2020;5(28):17347-17355doi: 10.1021/acsomega.0c01704.
Velasco-Rodriguez, B., Soltero-Martínez, J. F., Rosales-Rivera, L. C., Macías-Balleza, E. R., Landázuri, G., & Larios-Durán, E. R. (2020). Adsorption and Interaction of Bovine Serum Albumin and Pluronic P103 Triblock Copolymer on a Gold Electrode: Double-Layer Capacitance Measurements. ACS omega, 5(28), 17347-17355. https://doi.org/10.1021/acsomega.0c01704
Velasco-Rodriguez, Brenda, et al. "Adsorption and Interaction of Bovine Serum Albumin and Pluronic P103 Triblock Copolymer on a Gold Electrode: Double-Layer Capacitance Measurements." ACS omega vol. 5,28 (2020): 17347-17355. doi: https://doi.org/10.1021/acsomega.0c01704
Velasco-Rodriguez B, Soltero-Martínez JF, Rosales-Rivera LC, Macías-Balleza ER, Landázuri G, Larios-Durán ER. Adsorption and Interaction of Bovine Serum Albumin and Pluronic P103 Triblock Copolymer on a Gold Electrode: Double-Layer Capacitance Measurements. ACS Omega. 2020 Jul 08;5(28):17347-17355. doi: 10.1021/acsomega.0c01704. eCollection 2020 Jul 21. PMID: 32715219; PMCID: PMC7377067.
Copy Download .nbib Format: NLM
A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.

Kansas journal of medicine

Aggarwal D, Heim AJ, Bittel B, Ford D, Dubinsky R, Gronseth G, Hairston V, Landazuri P, Sachen F, Herbelin L, Barohn RJ.
PMID: 32256967
Kans J Med. 2020 Feb 26;13:2-5. eCollection 2020.

INTRODUCTION: Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antagonist, where the primary use is for glaucoma. There have been case reports that timolol is...

Cite
Aggarwal D, Heim AJ, Bittel B, et al. A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kans J Med. 2020;13:2-5
Aggarwal, D., Heim, A. J., Bittel, B., Ford, D., Dubinsky, R., Gronseth, G., Hairston, V., Landazuri, P., Sachen, F., Herbelin, L., & Barohn, R. J. (2020). A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kansas journal of medicine, 132-5.
Aggarwal, Dipika, et al. "A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine." Kansas journal of medicine vol. 13 (2020): 2-5.
Aggarwal D, Heim AJ, Bittel B, Ford D, Dubinsky R, Gronseth G, Hairston V, Landazuri P, Sachen F, Herbelin L, Barohn RJ. A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kans J Med. 2020 Feb 26;13:2-5. eCollection 2020. PMID: 32256967; PMCID: PMC7106987.
Copy Download .nbib Format: NLM
Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus.

Case reports in neurology

Uysal U, Landazuri P, Pearson C, Mittal M, Hammond N.
PMID: 28966587
Case Rep Neurol. 2017 Aug 23;9(2):195-203. doi: 10.1159/000479584. eCollection 2017.

BACKGROUND: Super-refractory status epilepticus (SRSE) is a critical neurological condition with a high mortality rate. There are only limited data to direct the treatment in SRSE, and surgery has been reported to successfully stop SRSE. We present a case...

Cite
Uysal U, Landazuri P, Pearson C, et al. Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus. Case Rep Neurol. 2017;9(2):195-203doi: 10.1159/000479584.
Uysal, U., Landazuri, P., Pearson, C., Mittal, M., & Hammond, N. (2017). Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus. Case reports in neurology, 9(2), 195-203. https://doi.org/10.1159/000479584
Uysal, Utku, et al. "Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus." Case reports in neurology vol. 9,2 (2017): 195-203. doi: https://doi.org/10.1159/000479584
Uysal U, Landazuri P, Pearson C, Mittal M, Hammond N. Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus. Case Rep Neurol. 2017 Aug 23;9(2):195-203. doi: 10.1159/000479584. eCollection 2017. PMID: 28966587; PMCID: PMC5618394.
Copy Download .nbib Format: NLM
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir.

Cell chemical biology

Zhang SM, Rehling D, Jemth AS, Throup A, Landázuri N, Almlöf I, Göttmann M, Valerie NCK, Borhade SR, Wakchaure P, Page BDG, Desroses M, Homan EJ, Scobie M, Rudd SG, Berglund UW, Söderberg-Nauclér C, Stenmark P, Helleday T.
PMID: 34192523
Cell Chem Biol. 2021 Dec 16;28(12):1693-1702.e6. doi: 10.1016/j.chembiol.2021.06.001. Epub 2021 Jun 29.

Ganciclovir (GCV) is the first-line therapy against human cytomegalovirus (HCMV), a widespread infection that is particularly dangerous for immunodeficient individuals. Closely resembling deoxyguanosine triphosphate, the tri-phosphorylated metabolite of GCV (GCV-TP) is preferentially incorporated by the viral DNA polymerase, thereby...

Cite
Zhang SM, Rehling D, Jemth AS, et al. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021;28(12):1693-1702.e6doi: 10.1016/j.chembiol.2021.06.001.
Zhang, S. M., Rehling, D., Jemth, A. S., Throup, A., Landázuri, N., Almlöf, I., Göttmann, M., Valerie, N. C. K., Borhade, S. R., Wakchaure, P., Page, B. D. G., Desroses, M., Homan, E. J., Scobie, M., Rudd, S. G., Berglund, U. W., Söderberg-Nauclér, C., Stenmark, P., & Helleday, T. (2021). NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell chemical biology, 28(12), 1693-1702.e6. https://doi.org/10.1016/j.chembiol.2021.06.001
Zhang, Si Min, et al. "NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir." Cell chemical biology vol. 28,12 (2021): 1693-1702.e6. doi: https://doi.org/10.1016/j.chembiol.2021.06.001
Zhang SM, Rehling D, Jemth AS, Throup A, Landázuri N, Almlöf I, Göttmann M, Valerie NCK, Borhade SR, Wakchaure P, Page BDG, Desroses M, Homan EJ, Scobie M, Rudd SG, Berglund UW, Söderberg-Nauclér C, Stenmark P, Helleday T. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021 Dec 16;28(12):1693-1702.e6. doi: 10.1016/j.chembiol.2021.06.001. Epub 2021 Jun 29. PMID: 34192523.
Copy Download .nbib Format: NLM
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir.

Cell chemical biology

Zhang SM, Rehling D, Jemth AS, Throup A, Landázuri N, Almlöf I, Göttmann M, Valerie NCK, Borhade SR, Wakchaure P, Page BDG, Desroses M, Homan EJ, Scobie M, Rudd SG, Berglund UW, Söderberg-Nauclér C, Stenmark P, Helleday T.
PMID: 34192523
Cell Chem Biol. 2021 Dec 16;28(12):1693-1702.e6. doi: 10.1016/j.chembiol.2021.06.001. Epub 2021 Jun 29.

Ganciclovir (GCV) is the first-line therapy against human cytomegalovirus (HCMV), a widespread infection that is particularly dangerous for immunodeficient individuals. Closely resembling deoxyguanosine triphosphate, the tri-phosphorylated metabolite of GCV (GCV-TP) is preferentially incorporated by the viral DNA polymerase, thereby...

Cite
Zhang SM, Rehling D, Jemth AS, et al. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021;28(12):1693-1702.e6doi: 10.1016/j.chembiol.2021.06.001.
Zhang, S. M., Rehling, D., Jemth, A. S., Throup, A., Landázuri, N., Almlöf, I., Göttmann, M., Valerie, N. C. K., Borhade, S. R., Wakchaure, P., Page, B. D. G., Desroses, M., Homan, E. J., Scobie, M., Rudd, S. G., Berglund, U. W., Söderberg-Nauclér, C., Stenmark, P., & Helleday, T. (2021). NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell chemical biology, 28(12), 1693-1702.e6. https://doi.org/10.1016/j.chembiol.2021.06.001
Zhang, Si Min, et al. "NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir." Cell chemical biology vol. 28,12 (2021): 1693-1702.e6. doi: https://doi.org/10.1016/j.chembiol.2021.06.001
Zhang SM, Rehling D, Jemth AS, Throup A, Landázuri N, Almlöf I, Göttmann M, Valerie NCK, Borhade SR, Wakchaure P, Page BDG, Desroses M, Homan EJ, Scobie M, Rudd SG, Berglund UW, Söderberg-Nauclér C, Stenmark P, Helleday T. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021 Dec 16;28(12):1693-1702.e6. doi: 10.1016/j.chembiol.2021.06.001. Epub 2021 Jun 29. PMID: 34192523.
Copy Download .nbib Format: NLM
The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection.

Cells

Landázuri N, Gorwood J, Terelius Y, Öberg F, Yaiw KC, Rahbar A, Söderberg-Nauclér C.
PMID: 34831300
Cells. 2021 Nov 08;10(11). doi: 10.3390/cells10113072.

Human cytomegalovirus (HCMV) infection is an important cause of morbidity and mortality in immunocompromised patients and a major etiological factor for congenital birth defects in newborns. Ganciclovir and its pro-drug valganciclovir are the preferred drugs in use today for...

Cite
Landázuri N, Gorwood J, Terelius Y, et al. The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection. Cells. 2021;10(11)doi: 10.3390/cells10113072.
Landázuri, N., Gorwood, J., Terelius, Y., Öberg, F., Yaiw, K. C., Rahbar, A., & Söderberg-Nauclér, C. (2021). The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection. Cells, 10(11), . https://doi.org/10.3390/cells10113072
Landázuri, Natalia, et al. "The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection." Cells vol. 10,11 (2021). doi: https://doi.org/10.3390/cells10113072
Landázuri N, Gorwood J, Terelius Y, Öberg F, Yaiw KC, Rahbar A, Söderberg-Nauclér C. The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection. Cells. 2021 Nov 08;10(11). doi: 10.3390/cells10113072. PMID: 34831300; PMCID: PMC8619441.
Copy Download .nbib Format: NLM
sEEG for expansion of a surgical epilepsy program: Safety and efficacy in 152 consecutive cases.

Epilepsia open

Miller C, Schatmeyer B, Landazuri P, Uysal U, Nazzaro J, Kinsman MJ, Camarata PJ, Ulloa CM, Hammond N, Pearson C, Shah V, Cheng JJ.
PMID: 34388309
Epilepsia Open. 2021 Dec;6(4):694-702. doi: 10.1002/epi4.12535. Epub 2021 Oct 30.

OBJECTIVE: Stereoelectroencephalography (sEEG) is an intracranial encephalography method of expanding use. The need for increased epilepsy surgery access has led to the consideration of sEEG adoption by new or expanding surgical epilepsy programs. Data regarding safety and efficacy are...

Cite
Miller C, Schatmeyer B, Landazuri P, et al. sEEG for expansion of a surgical epilepsy program: Safety and efficacy in 152 consecutive cases. Epilepsia Open. 2021;6(4):694-702doi: 10.1002/epi4.12535.
Miller, C., Schatmeyer, B., Landazuri, P., Uysal, U., Nazzaro, J., Kinsman, M. J., Camarata, P. J., Ulloa, C. M., Hammond, N., Pearson, C., Shah, V., & Cheng, J. J. (2021). sEEG for expansion of a surgical epilepsy program: Safety and efficacy in 152 consecutive cases. Epilepsia open, 6(4), 694-702. https://doi.org/10.1002/epi4.12535
Miller, Christopher, et al. "sEEG for expansion of a surgical epilepsy program: Safety and efficacy in 152 consecutive cases." Epilepsia open vol. 6,4 (2021): 694-702. doi: https://doi.org/10.1002/epi4.12535
Miller C, Schatmeyer B, Landazuri P, Uysal U, Nazzaro J, Kinsman MJ, Camarata PJ, Ulloa CM, Hammond N, Pearson C, Shah V, Cheng JJ. sEEG for expansion of a surgical epilepsy program: Safety and efficacy in 152 consecutive cases. Epilepsia Open. 2021 Dec;6(4):694-702. doi: 10.1002/epi4.12535. Epub 2021 Oct 30. PMID: 34388309; PMCID: PMC8633478.
Copy Download .nbib Format: NLM
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir.

Cell chemical biology

Zhang SM, Rehling D, Jemth AS, Throup A, Landázuri N, Almlöf I, Göttmann M, Valerie NCK, Borhade SR, Wakchaure P, Page BDG, Desroses M, Homan EJ, Scobie M, Rudd SG, Berglund UW, Söderberg-Nauclér C, Stenmark P, Helleday T.
PMID: 34192523
Cell Chem Biol. 2021 Dec 16;28(12):1693-1702.e6. doi: 10.1016/j.chembiol.2021.06.001. Epub 2021 Jun 29.

Ganciclovir (GCV) is the first-line therapy against human cytomegalovirus (HCMV), a widespread infection that is particularly dangerous for immunodeficient individuals. Closely resembling deoxyguanosine triphosphate, the tri-phosphorylated metabolite of GCV (GCV-TP) is preferentially incorporated by the viral DNA polymerase, thereby...

Cite
Zhang SM, Rehling D, Jemth AS, et al. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021;28(12):1693-1702.e6doi: 10.1016/j.chembiol.2021.06.001.
Zhang, S. M., Rehling, D., Jemth, A. S., Throup, A., Landázuri, N., Almlöf, I., Göttmann, M., Valerie, N. C. K., Borhade, S. R., Wakchaure, P., Page, B. D. G., Desroses, M., Homan, E. J., Scobie, M., Rudd, S. G., Berglund, U. W., Söderberg-Nauclér, C., Stenmark, P., & Helleday, T. (2021). NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell chemical biology, 28(12), 1693-1702.e6. https://doi.org/10.1016/j.chembiol.2021.06.001
Zhang, Si Min, et al. "NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir." Cell chemical biology vol. 28,12 (2021): 1693-1702.e6. doi: https://doi.org/10.1016/j.chembiol.2021.06.001
Zhang SM, Rehling D, Jemth AS, Throup A, Landázuri N, Almlöf I, Göttmann M, Valerie NCK, Borhade SR, Wakchaure P, Page BDG, Desroses M, Homan EJ, Scobie M, Rudd SG, Berglund UW, Söderberg-Nauclér C, Stenmark P, Helleday T. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir. Cell Chem Biol. 2021 Dec 16;28(12):1693-1702.e6. doi: 10.1016/j.chembiol.2021.06.001. Epub 2021 Jun 29. PMID: 34192523.
Copy Download .nbib Format: NLM
A case report of a Wada test after dominant hemisphere multiple hippocampal transections: Pathophysiology of confusion after amobarbital injection.

Epilepsy & behavior case reports

Landazuri P, Miller J, Lüders H.
PMID: 25667890
Epilepsy Behav Case Rep. 2014 Jun 14;2:130-2. doi: 10.1016/j.ebcr.2014.05.003. eCollection 2014.

Dialepsis is defined as a predominant alteration of consciousness with preservation of motor tone and the ability to perform movements. While dialepsis is a common feature of both focal and generalized epilepsies, its precise symptomatogenic zone and pathogenesis remain...

Cite
Landazuri P, Miller J, Lüders H. A case report of a Wada test after dominant hemisphere multiple hippocampal transections: Pathophysiology of confusion after amobarbital injection. Epilepsy Behav Case Rep. 2014;2:130-2doi: 10.1016/j.ebcr.2014.05.003.
Landazuri, P., Miller, J., & Lüders, H. (2014). A case report of a Wada test after dominant hemisphere multiple hippocampal transections: Pathophysiology of confusion after amobarbital injection. Epilepsy & behavior case reports, 2130-2. https://doi.org/10.1016/j.ebcr.2014.05.003
Landazuri, Patrick, et al. "A case report of a Wada test after dominant hemisphere multiple hippocampal transections: Pathophysiology of confusion after amobarbital injection." Epilepsy & behavior case reports vol. 2 (2014): 130-2. doi: https://doi.org/10.1016/j.ebcr.2014.05.003
Landazuri P, Miller J, Lüders H. A case report of a Wada test after dominant hemisphere multiple hippocampal transections: Pathophysiology of confusion after amobarbital injection. Epilepsy Behav Case Rep. 2014 Jun 14;2:130-2. doi: 10.1016/j.ebcr.2014.05.003. eCollection 2014. PMID: 25667890; PMCID: PMC4307959.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 18 entries